Your browser doesn't support javascript.
loading
Outcome of Allogeneic Hematopoietic Cell Transplantation after Venetoclax and Hypomethylating Agent Therapy for Acute Myelogenous Leukemia.
Sandhu, Karamjeet S; Dadwal, Sanjeet; Yang, Dongyun; Mei, Matthew; Palmer, Joycelynne; Salhotra, Amandeep; Al Malki, Monzr; Aribi, Ahmed; Ali, Haris; Khaled, Samer; Forman, Stephen J; Snyder, David; Nakamura, Ryotaro; Stein, Anthony S; Marcucci, Guido; Aldoss, Ibrahim; Pullarkat, Vinod.
Affiliation
  • Sandhu KS; Department of Hematology and Hematopoietic Cell Transplantation, Gehr Family Center for Leukemia Research, City of Hope Medical Center, Duarte, California.
  • Dadwal S; Department of Hematology and Hematopoietic Cell Transplantation, Gehr Family Center for Leukemia Research, City of Hope Medical Center, Duarte, California.
  • Yang D; Department of Hematology and Hematopoietic Cell Transplantation, Gehr Family Center for Leukemia Research, City of Hope Medical Center, Duarte, California.
  • Mei M; Department of Hematology and Hematopoietic Cell Transplantation, Gehr Family Center for Leukemia Research, City of Hope Medical Center, Duarte, California.
  • Palmer J; Department of Hematology and Hematopoietic Cell Transplantation, Gehr Family Center for Leukemia Research, City of Hope Medical Center, Duarte, California.
  • Salhotra A; Department of Hematology and Hematopoietic Cell Transplantation, Gehr Family Center for Leukemia Research, City of Hope Medical Center, Duarte, California.
  • Al Malki M; Department of Hematology and Hematopoietic Cell Transplantation, Gehr Family Center for Leukemia Research, City of Hope Medical Center, Duarte, California.
  • Aribi A; Department of Hematology and Hematopoietic Cell Transplantation, Gehr Family Center for Leukemia Research, City of Hope Medical Center, Duarte, California.
  • Ali H; Department of Hematology and Hematopoietic Cell Transplantation, Gehr Family Center for Leukemia Research, City of Hope Medical Center, Duarte, California.
  • Khaled S; Department of Hematology and Hematopoietic Cell Transplantation, Gehr Family Center for Leukemia Research, City of Hope Medical Center, Duarte, California.
  • Forman SJ; Department of Hematology and Hematopoietic Cell Transplantation, Gehr Family Center for Leukemia Research, City of Hope Medical Center, Duarte, California.
  • Snyder D; Department of Hematology and Hematopoietic Cell Transplantation, Gehr Family Center for Leukemia Research, City of Hope Medical Center, Duarte, California.
  • Nakamura R; Department of Hematology and Hematopoietic Cell Transplantation, Gehr Family Center for Leukemia Research, City of Hope Medical Center, Duarte, California.
  • Stein AS; Department of Hematology and Hematopoietic Cell Transplantation, Gehr Family Center for Leukemia Research, City of Hope Medical Center, Duarte, California.
  • Marcucci G; Department of Hematology and Hematopoietic Cell Transplantation, Gehr Family Center for Leukemia Research, City of Hope Medical Center, Duarte, California.
  • Aldoss I; Department of Hematology and Hematopoietic Cell Transplantation, Gehr Family Center for Leukemia Research, City of Hope Medical Center, Duarte, California.
  • Pullarkat V; Department of Hematology and Hematopoietic Cell Transplantation, Gehr Family Center for Leukemia Research, City of Hope Medical Center, Duarte, California. Electronic address: vpullarkat@coh.org.
Biol Blood Marrow Transplant ; 26(12): e322-e327, 2020 12.
Article de En | MEDLINE | ID: mdl-32866594

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Leucémie aigüe myéloïde / Transplantation de cellules souches hématopoïétiques Type d'étude: Observational_studies / Risk_factors_studies Limites: Humans / Middle aged Langue: En Journal: Biol Blood Marrow Transplant Sujet du journal: HEMATOLOGIA / TRANSPLANTE Année: 2020 Type de document: Article

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Leucémie aigüe myéloïde / Transplantation de cellules souches hématopoïétiques Type d'étude: Observational_studies / Risk_factors_studies Limites: Humans / Middle aged Langue: En Journal: Biol Blood Marrow Transplant Sujet du journal: HEMATOLOGIA / TRANSPLANTE Année: 2020 Type de document: Article